Author - Med Infinity

MedInfinity Inc. joins PSPO in its 19th PSPO Scientific Meeting

Last November 14 to 15, the Philippine Society of Pediatric Oncology (PSPO) held its 19th PSPO Scientific Meeting at Antonio Resort in Roxas City. PSPO is affiliated with 2 of MedInfinity Inc.'s (MII) partner hospitals namely: University of the Philippines - Philippine General Hospital (UP-PGH), and Philippine Children's Medical [...]

Strides toward the continuous development of its member competency

In line with company’s vision to become one of the best pharmaceutical distribution companies in the Philippines specializing in oncology, the company acknowledges the need for competent and skilled manpower. To achieve this, the company invests in providing training programs to ensure that its members’ skills are continuously honed. [...]

MII Onco. first to launch world’s first approved biosimilar Trastuzumab in Ph

  Last October 2017 , MedInfinity Oncology launched the world's first approved biosimilar Trastuzumab in Philippines during the SMO Annual Convention held at EDSA Shangri-la. The company was trusted by one of the most renowned international manufacturers based in the Netherlands to introduce their formulation to the Philippine oncology market. [...]